生物标志物的临床使用在心脏粉样化症中
Andrea Lalario1, Riccardo Saro1, Gianfranco Sinagra1
1Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Via P. Valdoni 7, 34100, Trieste, Italy; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Via P. Valdoni 7, 34100, Trieste, Italy.
Heart failure clinics
|June 6, 2024
概括
生物标志物是诊断和管理心脏粉样性粉症的关键非侵入性工具. 本综述强调了它们目前的临床用途和患者评估中的未来潜力.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 内部医学 内部医学
背景情况:
- 氨基粉症是一种全身性疾病,影响多个器官.
- 建议在患者评估中采用多学科的方法.
- 生物标志物是疾病怀疑和管理的重要非侵入性工具.
研究的目的:
- 为心脏粉症中生物标志物的临床使用提供更新的重点.
- 强调生物标志物在诊断和预后中的作用.
- 讨论新兴生物标志物的未来前景.
主要方法:
- 关于心脏粉症中的生物标志物的当代研究的文献综述.
- 分析当前生物标志物的诊断和预后应用.
- 探索新兴生物标记技术及其潜在影响.
主要成果:
- 生物标志物显著有助于增加对心脏粉样化症的怀疑.
- 当前生物标志物在诊断和预后评估中起着至关重要的作用.
- 新兴的生物标志物显示出未来临床应用的前景.
结论:
- 生物标志物对于心脏粉样性病的综合管理是不可或缺的.
- 对新型生物标志物的持续研究将提高诊断准确性和预后能力.
- 综合生物标志物的多模式方法是最佳患者护理的关键.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
137
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77